Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1989 May;65(763):291–298. doi: 10.1136/pgmj.65.763.291

Chemotherapy in lung cancer.

C G Price 1, M L Slevin 1
PMCID: PMC2429318  PMID: 2558370

Full text

PDF
291

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bakker W., van Oosterom A. T., Aaronson N. K., van Breukelen F. J., Bins M. C., Hermans J. Vindesine, cisplatin, and bleomycin combination chemotherapy in non-small cell lung cancer: survival and quality of life. Eur J Cancer Clin Oncol. 1986 Aug;22(8):963–970. doi: 10.1016/0277-5379(86)90063-5. [DOI] [PubMed] [Google Scholar]
  2. Bronchud M. H., Scarffe J. H., Thatcher N., Crowther D., Souza L. M., Alton N. K., Testa N. G., Dexter T. M. Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br J Cancer. 1987 Dec;56(6):809–813. doi: 10.1038/bjc.1987.295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Buckner C. D., Briggs R., Clift R. A., Fefer A., Funk D. D., Glucksberg H., Neiman P. E., Storb R., Thomas E. D. Intermittent high-dose cyclophosphamide (NSC-26271) treatment of stage III ovarian carcinoma. Cancer Chemother Rep. 1974 Sep-Oct;58(5 Pt 1):697–703. [PubMed] [Google Scholar]
  4. Bunn P. A., Jr, Nugent J. L., Matthews M. J. Central nervous system metastases in small cell bronchogenic carcinoma. Semin Oncol. 1978 Sep;5(3):314–322. [PubMed] [Google Scholar]
  5. Cornbleet M. A., McElwain T. J., Kumar P. J., Filshie J., Selby P., Carter R. L., Hedley D. W., Clark M. L., Millar J. L. Treatment of advanced malignant melanoma with high-dose melphalan and autologous bone marrow transplantation. Br J Cancer. 1983 Sep;48(3):329–334. doi: 10.1038/bjc.1983.196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dorward A. J., Banham S. W., Hutcheon A. W., Ahmedzai S., Cunningham D., Gregor A., Soukop M., Stack B. H., Mackay N. S., Kaye S. B. Short duration combination chemotherapy in the treatment of small cell lung cancer. Thorax. 1986 Sep;41(9):688–691. doi: 10.1136/thx.41.9.688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Evans W. K., Feld R., Murray N., Willan A., Coy P., Osoba D., Shepherd F. A., Clark D. A., Levitt M., MacDonald A. Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. A multicenter, randomized clinical trial by the National Cancer Institute of Canada. Ann Intern Med. 1987 Oct;107(4):451–458. doi: 10.7326/0003-4819-107-4-451. [DOI] [PubMed] [Google Scholar]
  8. Feld R., Evans W. K., DeBoer G., Quirt I. C., Shepherd F. A., Yeoh J. L., Pringle J. F., Payne D. G., Herman J. G., Chamberlain D. Combined modality induction therapy without maintenance chemotherapy for small cell carcinoma of the lung. J Clin Oncol. 1984 Apr;2(4):294–304. doi: 10.1200/JCO.1984.2.4.294. [DOI] [PubMed] [Google Scholar]
  9. Feld R. Quality of life in patients with non-small cell lung cancer treated with chemotherapy. Eur J Cancer Clin Oncol. 1987 Apr;23(4):357–359. doi: 10.1016/0277-5379(87)90369-5. [DOI] [PubMed] [Google Scholar]
  10. Fox R. M., Woods R. L., Brodie G. N., Tattersall M. H. A randomized study: small cell anaplastic lung cancer treated by combination chemotherapy and adjuvant radiotherapy. Int J Radiat Oncol Biol Phys. 1980 Aug;6(8):1083–1085. doi: 10.1016/0360-3016(80)90124-8. [DOI] [PubMed] [Google Scholar]
  11. Goldie J. H., Coldman A. J., Gudauskas G. A. Rationale for the use of alternating non-cross-resistant chemotherapy. Cancer Treat Rep. 1982 Mar;66(3):439–449. [PubMed] [Google Scholar]
  12. Greco F. A. Rationale for chemotherapy for patients with advanced non-small-cell lung cancer. Semin Oncol. 1986 Sep;13(3 Suppl 3):92–96. [PubMed] [Google Scholar]
  13. Green R. A., Humphrey E., Close H., Patno M. E. Alkylating agents in bronchogenic carcinoma. Am J Med. 1969 Apr;46(4):516–525. doi: 10.1016/0002-9343(69)90071-0. [DOI] [PubMed] [Google Scholar]
  14. Hansen H. H., Elliott J. A. Patterns of failure in small cell lung cancer: implications for therapy. Recent Results Cancer Res. 1984;92:43–57. doi: 10.1007/978-3-642-82218-6_4. [DOI] [PubMed] [Google Scholar]
  15. Hansen H. H., Hansen M. Tumor markers in small cell lung cancer. Eur J Cancer Clin Oncol. 1987 Nov;23(11):1585–1587. doi: 10.1016/0277-5379(87)90435-4. [DOI] [PubMed] [Google Scholar]
  16. Harvey V. J., Slevin M. L., Cheek S. P., Barnett M. J., Gregory W., Thompson J. P., Wrigley P. F. A randomized trial comparing vindesine and cisplatinum to vindesine and methotrexate in advanced non small cell lung carcinoma. Eur J Cancer Clin Oncol. 1987 Nov;23(11):1615–1619. doi: 10.1016/0277-5379(87)90439-1. [DOI] [PubMed] [Google Scholar]
  17. Havemann K., Wolf M., Holle R., Gropp C., Drings P., Manke H. G., Hans K., Schroeder M., Heim M., Victor N. Alternating versus sequential chemotherapy in small cell lung cancer. A randomized German multicenter trial. Cancer. 1987 Mar 15;59(6):1072–1082. doi: 10.1002/1097-0142(19870315)59:6<1072::aid-cncr2820590605>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  18. Johnson B. E., Becker B., Goff W. B., 2nd, Petronas N., Krehbiel M. A., Makuch R. W., McKenna G., Glatstein E., Ihde D. C. Neurologic, neuropsychologic, and computed cranial tomography scan abnormalities in 2- to 10-year survivors of small-cell lung cancer. J Clin Oncol. 1985 Dec;3(12):1659–1667. doi: 10.1200/JCO.1985.3.12.1659. [DOI] [PubMed] [Google Scholar]
  19. Johnson B. E., Ihde D. C., Bunn P. A., Becker B., Walsh T., Weinstein Z. R., Matthews M. J., Whang-Peng J., Makuch R. W., Johnston-Early A. Patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. Data on potential cures, chronic toxicities, and late relapses after a five- to eleven-year follow-up. Ann Intern Med. 1985 Sep;103(3):430–438. doi: 10.7326/0003-4819-103-3-430. [DOI] [PubMed] [Google Scholar]
  20. Klastersky J. VP-16 and cisplatin in the treatment of non-small-cell lung cancer. Semin Oncol. 1985 Mar;12(1 Suppl 2):17–20. [PubMed] [Google Scholar]
  21. Livingston R. B., Stephens R. L., Bonnet J. D., Grozea P. N., Lehane D. E. Long-term survival and toxicity in small cell lung cancer. Southwest Oncology Group study. Am J Med. 1984 Sep;77(3):415–417. doi: 10.1016/0002-9343(84)90095-0. [DOI] [PubMed] [Google Scholar]
  22. Maurer L. H., Pajak T. F. Prognostic factors in small cell carcinoma of the lung: a cancer and leukemia group B study. Cancer Treat Rep. 1981 Sep-Oct;65(9-10):767–774. [PubMed] [Google Scholar]
  23. Morgan D. A., Gilson D., Fletcher J. Vincristine and etoposide: an effective chemotherapy regimen with reduced toxicity in extensive small-cell lung cancer. Eur J Cancer Clin Oncol. 1987 Jun;23(6):619–621. doi: 10.1016/0277-5379(87)90256-2. [DOI] [PubMed] [Google Scholar]
  24. Niiranen A. Long-term survival in small cell carcinoma of the lung. Eur J Cancer Clin Oncol. 1988 Apr;24(4):749–752. doi: 10.1016/0277-5379(88)90310-0. [DOI] [PubMed] [Google Scholar]
  25. Nugent J. L., Bunn P. A., Jr, Matthews M. J., Ihde D. C., Cohen M. H., Gazdar A., Minna J. D. CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival. Cancer. 1979 Nov;44(5):1885–1893. doi: 10.1002/1097-0142(197911)44:5<1885::aid-cncr2820440550>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  26. Osoba D., Rusthoven J. J., Evans W. K., Turnbull K. A. Combined chemotherapy and radiation therapy for non-small-cell lung cancer. Semin Oncol. 1986 Sep;13(3 Suppl 3):121–124. [PubMed] [Google Scholar]
  27. Osoba D., Rusthoven J. J., Turnbull K. A., Evans W. K., Shepherd F. A. Combination chemotherapy with bleomycin, etoposide, and cisplatin in metastatic non-small-cell lung cancer. J Clin Oncol. 1985 Nov;3(11):1478–1485. doi: 10.1200/JCO.1985.3.11.1478. [DOI] [PubMed] [Google Scholar]
  28. Paulson D. L., Reisch J. S. Long-term survival after resection for bronchogenic carcinoma. Ann Surg. 1976 Sep;184(3):324–332. doi: 10.1097/00000658-197609000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Pedersen A. G., Hansen H. H. Etoposide (VP-16) in the treatment of lung cancer. Cancer Treat Rev. 1983 Dec;10(4):245–264. doi: 10.1016/0305-7372(83)90013-0. [DOI] [PubMed] [Google Scholar]
  30. Perry M. C., Eaton W. L., Propert K. J., Ware J. H., Zimmer B., Chahinian A. P., Skarin A., Carey R. W., Kreisman H., Faulkner C. Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung. N Engl J Med. 1987 Apr 9;316(15):912–918. doi: 10.1056/NEJM198704093161504. [DOI] [PubMed] [Google Scholar]
  31. Poplin E., Thompson B., Whitacre M., Aisner J. Small cell carcinoma of the lung: influence of age on treatment outcome. Cancer Treat Rep. 1987 Mar;71(3):291–296. [PubMed] [Google Scholar]
  32. Price P., Hoskin P. J., Easton D., Austin D., Palmer S. G., Yarnold J. R. Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases. Radiother Oncol. 1986 Aug;6(4):247–255. doi: 10.1016/s0167-8140(86)80191-8. [DOI] [PubMed] [Google Scholar]
  33. Rudnick S. A., Feinstein A. R. An analysis of the reporting of results in lung cancer drug trials. J Natl Cancer Inst. 1980 Jun;64(6):1337–1343. doi: 10.1093/jnci/64.6.1337. [DOI] [PubMed] [Google Scholar]
  34. Smith I. E., Evans B. D., Gore M. E., Vincent M. D., Repetto L., Yarnold J. R., Ford H. T. Carboplatin (Paraplatin; JM8) and etoposide (VP-16) as first-line combination therapy for small-cell lung cancer. J Clin Oncol. 1987 Feb;5(2):185–189. doi: 10.1200/JCO.1987.5.2.185. [DOI] [PubMed] [Google Scholar]
  35. Smith I. E., Harland S. J., Robinson B. A., Evans B. D., Goodhart L. C., Calvert A. H., Yarnold J., Glees J. P., Baker J., Ford H. T. Carboplatin: a very active new cisplatin analog in the treatment of small cell lung cancer. Cancer Treat Rep. 1985 Jan;69(1):43–46. [PubMed] [Google Scholar]
  36. Souhami R. L., Bradbury I., Geddes D. M., Spiro S. G., Harper P. G., Tobias J. S. Prognostic significance of laboratory parameters measured at diagnosis in small cell carcinoma of the lung. Cancer Res. 1985 Jun;45(6):2878–2882. [PubMed] [Google Scholar]
  37. Souhami R. L., Geddes D. M., Spiro S. G., Harper P. G., Tobias J. S., Mantell B. S., Fearon F., Bradbury I. Radiotherapy in small cell cancer of the lung treated with combination chemotherapy: a controlled trial. Br Med J (Clin Res Ed) 1984 Jun 2;288(6431):1643–1646. doi: 10.1136/bmj.288.6431.1643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Souhami R. L., Harper P. G., Linch D., Trask C., Goldstone A. H., Tobias J. S., Spiro S. G., Geddes D. M., Richards J. D. High-dose cyclophosphamide with autologous marrow transplantation for small cell carcinoma of the bronchus. Cancer Chemother Pharmacol. 1983;10(3):205–207. doi: 10.1007/BF00255764. [DOI] [PubMed] [Google Scholar]
  39. Stanley K. E. Prognostic factors for survival in patients with inoperable lung cancer. J Natl Cancer Inst. 1980 Jul;65(1):25–32. [PubMed] [Google Scholar]
  40. Stewart P., Buckner C. D., Thomas E. D., Bagley C., Bensinger W., Clift R. A., Appelbaum F. R., Sanders J. Intensive chemoradiotherapy with autologous marrow transplantation for small cell carcinoma of the lung. Cancer Treat Rep. 1983 Dec;67(12):1055–1059. [PubMed] [Google Scholar]
  41. Vincent M. D., Ashley S. E., Smith I. E. Prognostic factors in small cell lung cancer: a simple prognostic index is better than conventional staging. Eur J Cancer Clin Oncol. 1987 Nov;23(11):1589–1599. doi: 10.1016/0277-5379(87)90436-6. [DOI] [PubMed] [Google Scholar]
  42. Vincent M., Evans B., Smith I. First-line chemotherapy rechallenge after relapse in small cell lung cancer. Cancer Chemother Pharmacol. 1988;21(1):45–48. doi: 10.1007/BF00262737. [DOI] [PubMed] [Google Scholar]
  43. Vogelsang G. B., Abeloff M. D., Ettinger D. S., Booker S. V. Long-term survivors of small cell carcinoma of the lung. Am J Med. 1985 Jul;79(1):49–56. doi: 10.1016/0002-9343(85)90545-5. [DOI] [PubMed] [Google Scholar]
  44. Zelen M. Keynote address on biostatistics and data retrieval. Cancer Chemother Rep 3. 1973 Mar;4(2):31–42. [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES